Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Paul A Bunn

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bunn, Paul

Item TypeName
Academic Article Methods for production of monoclonal antibodies with specificity for human lung cancer cells.
Academic Article Herpes zoster and small cell bronchogenic carcinoma.
Academic Article Evaluation of response to chemotherapy with fiberoptic bronchoscopy in non-small cell lung cancer.
Academic Article Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).
Academic Article Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer.
Academic Article Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience.
Academic Article Abdominal computed tomography in small cell lung cancer: assessment of extent of disease and response to therapy.
Academic Article Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung.
Academic Article The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes.
Academic Article Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer. Potential benefit restricted to patients with complete response.
Academic Article Small cell lung cancer 1973-1983: early progress and recent obstacles.
Academic Article Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy.
Academic Article Perirectal infections in patients with small cell lung cancer.
Academic Article Possible enhancement of vincristine neuropathy by VP-16.
Academic Article Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin C.
Academic Article Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy.
Academic Article A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study.
Academic Article Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Academic Article New treatment agents for advanced small cell and non-small cell lung cancer.
Academic Article A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: a University of Colorado Cancer Center study.
Academic Article Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity.
Academic Article Combined modality therapy in small cell lung cancer.
Academic Article Secondary screening system for preclinical testing of human lung cancer therapies.
Academic Article The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Academic Article Controversies in the nonsurgical treatment of stage III non-small cell lung cancer.
Academic Article Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl.
Academic Article Clinical experiences with carboplatin (paraplatin) in lung cancer.
Academic Article The role of routine chest radiotherapy in small-cell lung cancer. An issue of timing and stage.
Academic Article Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
Academic Article Smoking abstinence and small cell lung cancer survival. An association.
Academic Article Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival.
Academic Article Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity.
Academic Article Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer.
Academic Article Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung.
Academic Article Phase II trial of cisplatin in small cell carcinoma of the lung.
Academic Article Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer.
Academic Article Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients.
Academic Article Small-cell carcinoma of lung: reinduction therapy after late relapse.
Academic Article Expansion of bronchial epithelial cell populations by in vitro culture of explants from dysplastic and histologically normal sites.
Academic Article Novel bradykinin antagonist dimers for the treatment of human lung cancers.
Academic Article Combination paclitaxel and platinum in the treatment of lung cancer: US experience.
Academic Article Future directions in therapeutic approaches for small cell lung cancer.
Academic Article 5th I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, Switzerland.
Academic Article The emerging role of gemcitabine in lung cancer: part I.
Academic Article Streptozotocin in advanced small cell bronchogenic carcinoma: an ineffective nonmyelosuppressive agent.
Academic Article Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.
Academic Article The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Academic Article Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team.
Academic Article Overview of chemotherapy for small cell lung cancer.
Academic Article A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer.
Academic Article The emerging role of gemcitabine in lung cancer.
Academic Article Systemic investigational therapies as adjuvants to surgery in patients with operable lung cancer.
Academic Article Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth.
Academic Article Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?
Academic Article Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
Academic Article New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma.
Academic Article Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team.
Academic Article New therapeutic strategies for lung cancer: biology and molecular biology come of age.
Academic Article Discordant signal transduction and growth inhibition of small cell lung carcinomas induced by expression of GTPase-deficient G alpha 16.
Academic Article New combinations in the treatment of lung cancer: a time for optimism.
Academic Article Altered HOX and WNT7A expression in human lung cancer.
Academic Article HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer.
Academic Article The inherited nature of lung cancer: a pilot study.
Academic Article Chemotherapy rather than demeclocycline for inappropriate secretion of antidiuretic hormone.
Academic Article Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Academic Article Current therapy of small cell lung cancer.
Academic Article Growth rates of small cell bronchogenic carcinomas.
Academic Article ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer.
Academic Article Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors.
Academic Article Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a "biased agonist" mechanism.
Academic Article Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas.
Academic Article Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Academic Article What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer?
Academic Article Central nervous system metastases in small cell bronchogenic carcinoma.
Academic Article Pemetrexed as a single agent in the therapy of advanced lung cancer.
Academic Article Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Academic Article Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
Academic Article HER2/neu expression in malignant lung tumors.
Academic Article Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
Academic Article Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?
Academic Article Lung cancer. Introduction.
Academic Article An update on North American randomized studies in non-small cell lung cancer.
Academic Article Triplet chemotherapy combinations with new agents: is there a rationale?
Academic Article Chemotherapy for elderly patients with advanced non-small-cell lung cancer.
Academic Article Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.
Academic Article Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo.
Academic Article Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know.
Academic Article Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
Academic Article Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.
Academic Article The future of cyclooxygenase-2 inhibitors and other inhibitors of the eicosanoid signal pathway in the prevention and therapy of lung cancer.
Academic Article The potential role of proteasome inhibitors in the treatment of lung cancer.
Academic Article A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorption.
Academic Article Chemoprevention of lung cancer--from biology to clinical reality.
Academic Article Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.
Academic Article Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
Academic Article Platinums in lung cancer: sufficient or necessary?
Academic Article Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Academic Article Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer.
Academic Article Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.
Academic Article Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.
Academic Article Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
Academic Article High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.
Academic Article Irradiated nude rat model for orthotopic human lung cancers.
Academic Article HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.
Academic Article Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy.
Academic Article Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.
Academic Article Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.
Academic Article Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.
Academic Article Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
Academic Article Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how?
Academic Article Operation for stage IIIa small cell lung cancer?
Academic Article Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
Academic Article From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
Academic Article Lack of association between sputum atypia and chronic obstructive pulmonary disease mortality.
Academic Article Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.
Academic Article Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.
Academic Article Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Academic Article Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
Academic Article Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
Academic Article Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
Academic Article Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer.
Academic Article EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.
Academic Article EGFR testing in lung cancer is ready for prime time.
Academic Article Novel therapies for non-small-cell lung cancer: a 2008 update.
Academic Article Innovative and future approaches to small cell lung cancer treatment.
Academic Article New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer.
Academic Article Optimal therapy for elderly patients with early stage non-small cell lung cancer.
Academic Article Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Academic Article A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Academic Article Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.
Academic Article The expanding role of cisplatin in the treatment of non-small-cell lung cancer.
Academic Article ZEB1-responsive genes in non-small cell lung cancer.
Academic Article Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?
Academic Article Advances in small cell bronchogenic carcinoma.
Academic Article Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
Academic Article Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk.
Academic Article A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer.
Academic Article Oral iloprost improves endobronchial dysplasia in former smokers.
Academic Article Seminars in oncology. Introduction.
Academic Article Epidermal growth factor receptor family in lung cancer and premalignancy.
Academic Article Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer.
Academic Article A new generation of EGFR tyrosine-kinase inhibitors in NSCLC.
Academic Article Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Academic Article Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy.
Academic Article Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.
Academic Article Non-invasive breath analysis of pulmonary nodules.
Academic Article Results of therapeutic cranial irradiation in small cell lung cancer.
Academic Article Characteristics of lung cancers harboring NRAS mutations.
Academic Article Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients.
Academic Article Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up.
Academic Article Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.
Academic Article Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer.
Academic Article Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies.
Academic Article Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer.
Academic Article New targeted therapies for lung cancer: expectations and reality.
Academic Article Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Academic Article Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties.
Academic Article Role of radiation therapy in small cell anaplastic carcinoma of the lung.
Academic Article Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response.
Academic Article Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy.
Academic Article A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC).
Academic Article Delayed hypersensitivity skin testing as a prognostic indicator in patients with small cell lung cancer.
Academic Article High-dose methotrexate with leucovorin rescue in patients with unresectable non-small cell carcinoma of the lung.
Academic Article Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer.
Academic Article Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
Academic Article Prophylactic cranial irradiation for patients with small-cell lung cancer.
Academic Article Irinotecan and platinums in the treatment of non small-cell lung cancer.
Academic Article Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer.
Academic Article Future directions in clinical research for lung cancer.
Academic Article High prevalence of endobronchial malignancy in high-risk patients with moderate dysplasia in sputum.
Academic Article Novel agents in the treatment of lung cancer: conference summary statement.
Academic Article European School of Oncology. First Euro-American Forum on Lung Cancer Treatment.
Academic Article Small cell lung cancer: etiology, biology, clinical features, staging, and treatment.
Academic Article Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study.
Academic Article Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Academic Article NCI-Navy Medical Oncology Branch cell line data base.
Academic Article Effects of neuropeptides on human lung and breast cancer cells.
Academic Article New investigative regimens and cytotoxic agents in thoracic cancers: gemcitabine and pemetrexed.
Academic Article Carboxypeptidase M. Variable expression in normal human lung and inactivation in lung cancer.
Academic Article A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
Academic Article The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Academic Article New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
Academic Article A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
Academic Article Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: similar survival to cisplatin plus vinorelbine and less toxicity.
Academic Article Immune therapy for lung cancer: are we getting closer?
Academic Article Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.
Academic Article Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
Academic Article Triplet combination chemotherapy and targeted therapy regimens.
Academic Article Maximum tolerated dose for low-dose continuous infusion cisplatin.
Academic Article Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
Academic Article Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.
Academic Article Growth factors in lung cancer: possible etiologic role and clinical target.
Academic Article [State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer].
Academic Article Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study.
Academic Article Neuropeptide stimulation of calcium flux in human lung cancer cells: delineation of alternative pathways.
Academic Article Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'.
Academic Article Serial fiberoptic bronchoscopy during chemotherapy for small cell carcinoma of the lung: early detection of patients at high risk of relapse.
Academic Article Bone marrow metastases in small cell carcinoma of the lung: frequency, description, and influence on chemotherapeutic toxicity and prognosis.
Academic Article Expression of target molecules in lung cancer: challenge for a new treatment paradigm.
Academic Article IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001.
Academic Article Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Academic Article Response to thoracic radiotherapy in patients with small cell carcinoma of the lung after failure of combination chemotherapy.
Academic Article CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival.
Academic Article Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.
Academic Article Ongoing and future trials of biologic therapies in lung cancer.
Academic Article Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody column.
Academic Article Targeting the epidermal growth factor receptor in non-small cell lung cancer.
Academic Article Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
Academic Article Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
Academic Article Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report.
Academic Article Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.
Academic Article Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma.
Academic Article A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer.
Academic Article Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer.
Academic Article Can acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors be overcome by different small-molecule tyrosine kinase inhibitors?
Academic Article Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations?
Academic Article Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.
Academic Article Adjuvant chemotherapy for resected non-small-cell lung cancer.
Academic Article Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.
Academic Article Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease.
Academic Article Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity.
Academic Article Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
Academic Article First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.
Academic Article Anti-growth factor therapy for lung cancer.
Academic Article Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Academic Article Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium.
Academic Article Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
Academic Article The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.
Academic Article Adjuvant chemotherapy for non-small cell lung cancer.
Academic Article Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
Academic Article Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.
Academic Article Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
Academic Article EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
Academic Article Diseases desperate grown.
Academic Article Review of therapeutic trials of carboplatin in lung cancer.
Academic Article The tissue is the issue: personalized medicine for non-small cell lung cancer.
Academic Article ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC).
Academic Article A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.
Academic Article Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express the Leu-7 antigenic determinant present on natural killer cells.
Academic Article Early-stage NSCLC: the role of radiotherapy and systemic therapy.
Academic Article MAGE A3 antigen-specific cancer immunotherapeutic.
Academic Article Genetic testing for lung cancer: reflex versus clinical selection.
Academic Article A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.
Academic Article Classification of lung cancer histology by gold nanoparticle sensors.
Academic Article Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.
Academic Article Worldwide overview of the current status of lung cancer diagnosis and treatment.
Academic Article Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.
Academic Article Origin of human small cell lung cancer.
Academic Article Biologically targeted therapies plus chemotherapy plus radiotherapy in stage III non-small-cell lung cancer: a case of the Icarus syndrome?
Academic Article Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.
Academic Article Lung cancer in 2013: state of the art therapy for metastatic disease.
Academic Article The role of radiation therapy in the treatment of small cell lung cancer.
Academic Article Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
Academic Article Automated fluorescent analysis for drug-induced cytotoxicity assays.
Academic Article Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
Academic Article Cerebrospinal fluid bombesin and calcitonin in patients with central nervous system metastases from small-cell lung cancer.
Academic Article Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial.
Academic Article Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.
Academic Article Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes in dogs: a new approach to lung cancer imaging.
Concept Lung Neoplasms
Academic Article Volatile fingerprints of cancer specific genetic mutations.
Academic Article The evolution of tumor classification: a role for genomics?
Academic Article Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer.
Academic Article Effective crizotinib schedule for brain metastases in ALK rearrangement metastatic non-small-cell lung cancer.
Academic Article Progress in research on screening and genetics in lung cancer.
Academic Article Recent clinical advances in lung cancer management.
Academic Article Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
Academic Article FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.
Academic Article Reply to A. Braillon.
Academic Article Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.
Academic Article Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Academic Article Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Academic Article Personalized one-two punches for lung cancer.
Academic Article Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Academic Article Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.
Academic Article Improving the Care of Patients With Stage IB Non-Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.
Academic Article Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.
Academic Article Adjuvant TKIs in NSCLC: what can we learn from RADIANT?
Academic Article Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma.
Academic Article Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
Academic Article Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer.
Academic Article Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
Academic Article Scientific Advances in Lung Cancer 2015.
Academic Article Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status.
Academic Article The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.
Academic Article Clinicopathologic Features of Advanced Squamous NSCLC.
Academic Article New and emerging targeted treatments in advanced non-small-cell lung cancer.
Academic Article Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.
Academic Article Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment.
Academic Article KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.
Academic Article Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal?from the Bench.
Academic Article Karnofsky Award 2016: A Lung Cancer Journey, 1973 to 2016.
Academic Article AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition.
Academic Article The role of irinotecan combined with Cisplatin or Carboplatin in the treatment of advanced non-small-cell lung cancer.
Academic Article Current therapeutic approaches in lung cancer.
Academic Article Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer.
Grant 7TH WORLD CONFERENCE ON LUNG CANCER
Grant Lung Cancer Mutation Analysis
Grant SPORE in Lung Cancer
Academic Article Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer.
Academic Article Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.
Academic Article HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.
Academic Article Small-cell lung cancer: what we know, what we need to know and the path forward.
Academic Article Small-cell lung cancer: what we know, what we need to know and the path forward.
Academic Article Advances in lung cancer.
Academic Article The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
Academic Article Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer.
Academic Article Eribulin inhibits the growth of small cell lung cancer cell lines alone and with radiotherapy.
Academic Article Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP).
Academic Article Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.
Academic Article The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC.
Academic Article Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
Academic Article Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Academic Article The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.
Academic Article Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial Dysplasia.
Academic Article Systemic Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancers.
Academic Article Broad-Based Molecular Testing for Lung Cancer: Precisely the Time for Precision.
Academic Article Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.
Academic Article HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib.
Academic Article Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer.
Academic Article Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133.
Academic Article New Developments in Neoadjuvant Therapy for Lung Cancer.
Academic Article Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.
Academic Article MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.
Academic Article A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers.
Academic Article Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
Academic Article Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance.
Academic Article IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
Academic Article Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer.
Academic Article Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.
Academic Article Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury.
Academic Article 2020 Innovation-Based Optimism for Lung Cancer Outcomes.
Academic Article Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations.
Academic Article Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation.
Academic Article Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer.
Academic Article International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials.
Academic Article RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer.
Academic Article Adjuvant Osimertinib in EGFR-Mutant Early-Stage NSCLC: Does HRQoL Influence Decisions?
Academic Article Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer.
Academic Article Longitudinal Analyses of COVID-19 Vaccination in Patients With Lung Cancer: Antibody Responses and Variant-Specific Neutralization.
Academic Article Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.
Academic Article Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer.
Academic Article Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Academic Article Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer.
Academic Article Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit.
Academic Article CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.
Academic Article Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy.
Academic Article Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
Academic Article International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
Academic Article Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Academic Article Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer.
Academic Article Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study.

Search Criteria
  • Lung cancer

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)